Principal Financial Group
ABEO icon

Principal Financial Group’s Abeona Therapeutics ABEO Stock Holding History

Principal Financial Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-783
Closed -$22K – 2525
2021
Q3 		$22K Sell
783
-127
-14% -$4.07K ﹤0.01% 2567
2021
Q2 		$35K Buy
+910
New +$37.1K ﹤0.01% 2590
2018
Q4 		– Sell
-1,068
Closed -$342K – 2241
2018
Q3 		$342K Buy
1,068
+20
+2% +$7.09K ﹤0.01% 2047
2018
Q2 		$419K Buy
1,048
+395
+60% +$173K ﹤0.01% 1999
2018
Q1 		$234K Buy
653
+60
+10% +$22.3K ﹤0.01% 2072
2017
Q4 		$235K Buy
+593
New +$245K ﹤0.01% 2102

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group's ABEO Position: Q4 2021 in Review

Principal Financial Group sold out of Abeona Therapeutics (ABEO) in Q4 2021, closing a stake of 783 shares — an estimated $22K sold.

Principal Financial Group first reported a position in ABEO in Q4 2017 and held it in 6 quarters. The position peaked at $419K in Q2 2018. 52 funds tracked by Wall St. Rank hold ABEO as of Q4 2021.

  • Principal Financial Group reported no remaining Abeona Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Principal Financial Group sold 783 Abeona Therapeutics shares in Q4 2021, an estimated $22K.
  • Principal Financial Group first reported a position in Abeona Therapeutics in Q4 2017 and held it in 6 quarters.
  • Principal Financial Group's Abeona Therapeutics position peaked at $419K in Q2 2018.
  • 52 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2021.

Based on Principal Financial Group's 13F filing for Q4 2021, filed 9 Feb 2022.